Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cytoplasmic membrane and cell wall anionic components, including phosphatidylglycerol, cardiolipin, and lipoteichoic acid, are essential for maintaining the structural integrity and electrochemical gradient of the bacterial cell (Nature Reviews Microbiology, 2014, 12(11):751-763). These negatively charged molecules facilitate ion homeostasis and serve as anchors for various surface proteins and enzymes involved in cell wall synthesis (Microbiology and Molecular Biology Reviews, 2013, 77(2):219-261). In clinical medicine, these components are the primary targets for several potent antibiotics used to treat multi-drug resistant infections (StatPearls, 2023, NBK470467). For example, daptomycin targets phosphatidylglycerol in the cytoplasmic membrane of Gram-positive bacteria, leading to calcium-dependent pore formation and rapid depolarization (Clinical Infectious Diseases, 2007, 45(Supplement_2):S136-S143). Polymyxins, such as colistin, interact with anionic sites in the lipopolysaccharide and phospholipids of Gram-negative bacteria to disrupt membrane stability (Pharmacological Reviews, 2014, 66(4):1110-1148). While highly effective, drugs targeting these components often face challenges related to resistance development and specific toxicities, such as nephrotoxicity or elevation of creatine phosphokinase levels (Journal of Antimicrobial Chemotherapy, 2015, 70(3):679-694). These anionic components are distinct from mammalian cell membranes, which are primarily composed of neutral zwitterionic lipids, providing a basis for selective toxicity (Biophysical Journal, 2016, 110(3):641-656).
Calcium-dependent binding to anionic lipids (specifically phosphatidylglycerol) leading to membrane depolarization, potassium ion efflux, and rapid cell death; displacement of divalent cations from anionic sites in the outer membrane (LPS) and cytoplasmic membrane causing physical disruption and lysis (StatPearls, 2023, NBK470467; Pharmacological Reviews, 2014, 66(4):1110-1148).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cytoplasmic membrane and cell wall anionic components.